SCHEMBL4939495

SCHEMBL4939495

Oc1ccccc1Nc1c2ccccc2nc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.67
KMT2A Q03164 6/20 0.67
GAA P10253 2/20 0.67
KDM1A O60341 6/20 0.64
POLB P06746 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAPT P10636 3/20 0.55
MAPK1 P28482 3/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
GFER P55789 2/20 0.54
RAD52 P43351 1/20 0.54
PIM1 P11309 1/20 0.51
KDM4E B2RXH2 2/20 0.50
ATM Q13315 2/20 0.50
CXCR2 P25025 1/20 0.50
LMNA P02545 1/20 0.50
RECQL P46063 1/20 0.50
MMP14 P50281 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20856475 0.83 KDM1A (0.60) MEN1KMT2AGAAKDM1APOLB
SCHEMBL17154467 0.80 KDM1A (0.58) MEN1KMT2AGAAKDM1APOLB
SCHEMBL23630584 0.80 KDM1A (0.78) MEN1KMT2AGAAKDM1APOLB
SCHEMBL15673424 0.79 KDM1A (0.66) MEN1KMT2AGAAKDM1APOLB
SCHEMBL9595420 0.79 KDM1A (0.60) MEN1KMT2AGAAKDM1APOLB
SCHEMBL13530954 0.78 KMT2A (0.55) MEN1KMT2AGAAKDM1APOLB
SCHEMBL9603057 0.75 KDM1A (0.55) MEN1KMT2AGAAKDM1APOLB
SCHEMBL4939506 0.74 KDM1A (0.75) MEN1KMT2AGAAKDM1APOLB
SCHEMBL902770 0.74 KDM1A (1.00) MEN1KMT2AKDM1APOLBL3MBTL1
SCHEMBL12019930 0.74 KDM1A (0.58) MEN1KMT2AGAAKDM1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176889-A1 9-anilinoacridine alkylating agents ACADEMIA SINICA (TW) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176889-A1 9-anilinoacridine alkylating agents BCL9, MCL1, BCL9L MEN1 1814/4885KMT2A 288/4885GAA 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.